AKT1 and neoplasm: Accumulating experimental evidence indicates that constitutive activation of the P13K/AKT signaling pathway is associated with tumor cell resistance to conventional chemotherapy32, 33, and Wang et al. noted that the effectiveness of TMZ is dramatically enhanced when STAT3 is inhibited34.